AngioDynamics, Inc. Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent
AngioDynamics, Inc. (ANGO) reported Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent of $0 for the 12-month period ending 2021-05-31, per its 10-K filed 2021-07-27.
Discontinued › Income Statement › Net Income
us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity · last filed 2021-07-27
- AngioDynamics, Inc. income (loss) from discontinued operations, net of tax, attributable to parent for the quarter ending 2020-05-31 was $0.00, a 100.00% decline year-over-year.
- AngioDynamics, Inc. income (loss) from discontinued operations, net of tax, attributable to parent for the quarter ending 2020-02-29 was $0.00, a 100.00% decline year-over-year.
- AngioDynamics, Inc. income (loss) from discontinued operations, net of tax, attributable to parent for the quarter ending 2019-11-30 was $0.00, a 100.00% decline year-over-year.
- AngioDynamics, Inc. income (loss) from discontinued operations, net of tax, attributable to parent for the quarter ending 2019-08-31 was $0.00, a 100.00% decline year-over-year.
- AngioDynamics, Inc. income (loss) from discontinued operations, net of tax, attributable to parent for fiscal 2021 was $0.00.
- AngioDynamics, Inc. income (loss) from discontinued operations, net of tax, attributable to parent for fiscal 2020 was $0.00, a 100.00% decline from fiscal 2019.
- AngioDynamics, Inc. income (loss) from discontinued operations, net of tax, attributable to parent for fiscal 2019 was $72.49M, a 221.27% increase from fiscal 2018.
- AngioDynamics, Inc. income (loss) from discontinued operations, net of tax, attributable to parent for fiscal 2018 was $22.56M, a 87.08% increase from fiscal 2017.
| Period end | Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent 3 month | Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent 6 month | Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent 9 month | Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent 12 month |
|---|---|---|---|---|
| 2021-05-31 | $0.00 10-K · filed 2021-07-27 | |||
| 2020-05-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-07-27 | $0.00 derived: sum of 2 quarters · filed 2021-07-27 | $0.00 derived: sum of 3 quarters · filed 2021-07-27 | $0.00 10-K · filed 2021-07-27 |
| 2020-02-29 | $0.00 10-Q · filed 2020-04-08 | $0.00 derived: sum of 2 quarters · filed 2020-04-08 | $0.00 10-Q · filed 2020-04-08 | $56.12M derived: sum of 4 quarters · filed 2020-08-10 |
| 2019-11-30 | $0.00 10-Q · filed 2020-01-08 | $0.00 10-Q · filed 2020-01-08 | $56.12M derived: sum of 3 quarters · filed 2020-08-10 | $61.52M derived: sum of 4 quarters · filed 2020-08-10 |
| 2019-08-31 | $0.00 10-Q · filed 2019-10-04 | $56.12M derived: sum of 2 quarters · filed 2020-08-10 | $61.52M derived: sum of 3 quarters · filed 2020-08-10 | $67.25M derived: sum of 4 quarters · filed 2020-08-10 |
| 2019-05-31 | $56.12M 10-K · filed 2020-08-10 | $61.52M derived: sum of 2 quarters · filed 2020-08-10 | $67.25M derived: sum of 3 quarters · filed 2020-08-10 | $72.49M 10-K · filed 2021-07-27 |
| 2019-02-28 | $5.41M 10-K · filed 2020-08-10 | $11.13M derived: sum of 2 quarters · filed 2020-08-10 | $16.37M 10-Q · filed 2020-04-08 | $25.18M derived: sum of 4 quarters · filed 2020-08-10 |
| 2018-11-30 | $5.73M 10-K · filed 2020-08-10 | $10.96M 10-Q · filed 2020-01-08 | $19.77M derived: sum of 3 quarters · filed 2020-08-10 | $23.89M derived: sum of 4 quarters · filed 2020-08-10 |
| 2018-08-31 | $5.24M 10-K · filed 2020-08-10 | $14.05M derived: sum of 2 quarters · filed 2020-08-10 | $18.16M derived: sum of 3 quarters · filed 2020-08-10 | $22.82M derived: sum of 4 quarters · filed 2020-08-10 |
| 2018-05-31 | $8.81M 10-K · filed 2019-07-25 | $12.93M derived: sum of 2 quarters · filed 2019-07-25 | $17.59M derived: sum of 3 quarters · filed 2019-07-25 | $22.56M 10-K · filed 2020-08-10 |
| 2018-02-28 | $4.12M 10-K · filed 2019-07-25 | $8.78M derived: sum of 2 quarters · filed 2019-07-25 | $13.75M derived: sum of 3 quarters · filed 2019-07-25 | |
| 2017-11-30 | $4.66M 10-K · filed 2019-07-25 | $9.63M derived: sum of 2 quarters · filed 2019-07-25 | ||
| 2017-08-31 | $4.97M 10-K · filed 2019-07-25 | |||
| 2017-05-31 | $12.06M 10-K · filed 2019-07-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |